Amicus Therapeutics

$22.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.23 (+1.02%) Today
$0.00 (0.00%) As of 9:07 PM UTC after-hours

Why Robinhood?

You can buy or sell FOLD and other stocks, options, and ETFs commission-free!

About FOLD

Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with rare metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Cranbury, NJ. The listed name for FOLD is Amicus Therapeutics, Inc. Common Stock.

CEO
John Francis Crowley
Employees
584
Headquarters
Cranbury, New Jersey
Founded
2002
Market Cap
5.93B
Price-Earnings Ratio
Dividend Yield
Average Volume
2.15M
High Today
$22.92
Low Today
$22.39
Open Price
$22.50
Volume
1.39M
52 Week High
$23.19
52 Week Low
$6.25

Collections

FOLD Earnings

-$0.39
-$0.26
-$0.13
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 1, Pre-Market

You May Also Like